CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to MESO

Rexlemestrocel-L + HA mixture

Phase 3
MESOBLAST LTD (MESO)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Jul '27
MESOPhase 3

Rexlemestrocel-L + HA mixture Phase 3 Est. Readout

Rexlemestrocel-L + HA mixture
Jul 2027~
CT.gov
00%
Competitive Landscape

0 competitors in Degenerative Disc Disease

View Full Landscape
Drug Information

Target Indication

Degenerative Disc Disease

Clinical Trial

NCT06325566

Last updated: 2/13/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.